AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17713794 — intervention group
Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 90
Study 16018337 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency EEG (HFE)
Number of subjects: 13
Study 16018337 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency band (LFB)
Number of subjects: 13
Study 12757116 — intervention group
Group type: EXPERIMENTAL
Intervention: Pump-assisted nutrition (G1)
Number of subjects: 50
Study 12757116 — intervention group
Group type: COMPARATOR
Intervention: Gravity-controlled nutrition (G2)
Number of subjects: 50
Study 10692926 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intravenous infusion of midazolam (0.2 mg/ml of normal saline at a rate of 1 mg/h)
Number of subjects: 48
Study 10692926 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 48
Study 9115974 — intervention group
Group type: EXPERIMENTAL
Intervention: Soya infant formula
Number of subjects: 19
Study 9115974 — intervention group
Group type: COMPARATOR
Intervention: Infant milk
Number of subjects: 19
Study 1787974 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin oral rinse
Number of subjects: 20
Study 1787974 — intervention group
Group type: COMPARATOR
Intervention: Placebo rinse (normal saline)
Number of subjects: 20
Study 6382127 — intervention group
Group type: EXPERIMENTAL
Intervention: Flubendazole (FZ) treatment
Number of subjects: 12
Study 6382127 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12
Study 29550314 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity troponin I (hsTnI) concentrations
Number of subjects: 1844
Study 29550314 — intervention group
Group type: COMPARATOR
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 1844
Study 28557049 — intervention group
Group type: EXPERIMENTAL
Intervention: REAL group (rTMS)
Number of subjects: 44
Study 28557049 — intervention group
Group type: COMPARATOR
Intervention: SHAM group (control)
Number of subjects: 44
Study 26460634 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 28
Study 26460634 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric training
Number of subjects: 28
Study 25454175 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT) with 5 fluorouracil (5FU) and Folinic Acid (6 cycles) in Arm B.
Number of subjects: 655
Study 25454175 — intervention group
Group type: COMPARATOR
Intervention: Follow-up (no adjuvant chemotherapy) in Arm A.
Number of subjects: 655
Study 22198972 — intervention group
Group type: EXPERIMENTAL
Intervention: Reward prediction error (RPE) induced by discarding chosen outcomes for personal payoffs.
Number of subjects: 33
Study 22198972 — intervention group
Group type: EXPERIMENTAL
Intervention: Reward prediction error (RPE) induced by discarding chosen outcomes for charity payoffs.
Number of subjects: 33
Study 22198972 — intervention group
Group type: EXPERIMENTAL
Intervention: Outcome orientation in charitable giving.
Number of subjects: 33
Study 21440831 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical phenylephrine (0.1 ml, 10%) administered twice in 5 minutes before surgery
Number of subjects: 57
Study 21440831 — intervention group
Group type: COMPARATOR
Intervention: No topical phenylephrine (control group)
Number of subjects: 57
Study 17553743 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5mg/24h rotigotine
Number of subjects: 341
Study 17553743 — intervention group
Group type: EXPERIMENTAL
Intervention: 1mg/24h rotigotine
Number of subjects: 341
Study 17553743 — intervention group
Group type: EXPERIMENTAL
Intervention: 2mg/24h rotigotine
Number of subjects: 341
Study 17553743 — intervention group
Group type: EXPERIMENTAL
Intervention: 3mg/24h rotigotine
Number of subjects: 341
Study 17553743 — intervention group
Group type: EXPERIMENTAL
Intervention: 4mg/24h rotigotine
Number of subjects: 341
Study 17553743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study 16611722 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent ice application (n = 43)
Number of subjects: 89
Study 16611722 — intervention group
Group type: COMPARATOR
Intervention: Standard ice application (n = 46)
Number of subjects: 89
Study 14662576 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride for smoking cessation
Number of subjects: 600
Study 14662576 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsmoking adult or children in the home
Number of subjects: 600
Study 14662576 — intervention group
Group type: EXPERIMENTAL
Intervention: Progress in stage of change
Number of subjects: 600
Study 14662576 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline preparatory stage of change
Number of subjects: 600
Study 14662576 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a nonsmoking partner
Number of subjects: 600
Study 14662576 — intervention group
Group type: EXPERIMENTAL
Intervention: Having children in the home
Number of subjects: 600
Study 11122830 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m(2) every 3 weeks
Number of subjects: 0
Study 11122830 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 100 mg/m(2)
Number of subjects: 0
Study 11122830 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine or ifosfamide (control)
Number of subjects: 0
Study 11122830 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (control)
Number of subjects: 0
Study 8707476 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrine treatment
Number of subjects: 12
Study 8707476 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-responders (Tacrine treatment)
Number of subjects: 12
Study 2000843 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher educational level
Number of subjects: 512
Study 2000843 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports activity score
Number of subjects: 512
Study 2000843 — intervention group
Group type: COMPARATOR
Intervention: Heavy smoking
Number of subjects: 512
Study 6873418 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulfate per os for 8 weeks (Ps group)
Number of subjects: 0
Study 6873418 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulfate per os for 8 weeks (PA group)
Number of subjects: 0
Study 6873418 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 0
Study 6873418 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (Ps and PA groups)
Number of subjects: 0
Study 30719553 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical examination including transvaginal ultrasound (CE/US)
Number of subjects: 26
Study 30719553 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 Tesla magnetic resonance imaging (MRI)
Number of subjects: 26
Study 28635018 — intervention group
Group type: EXPERIMENTAL
Intervention: guselkumab 100 mg
Number of subjects: 268
Study 28635018 — intervention group
Group type: COMPARATOR
Intervention: ustekinumab
Number of subjects: 268
Study 27004293 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicortical fixation
Number of subjects: 38
Study 27004293 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicortical fixation
Number of subjects: 38
Study 27004293 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect sinus elevation
Number of subjects: 38
Study 24642082 — intervention group
Group type: EXPERIMENTAL
Intervention: Email and SMS prompts to revisit the intervention website
Number of subjects: 1124